Keynote – On the atherogenicity of remnant particles: Novel genetic insights
Dr Elias BjörnsonWatch the presentation >
Insights into apoC3’s mechanism of action
Karin BornfeldtWatch the presentation >
CVD risk reduction in HIV infection: The REPRIEVE Trial
Steven GrinspoonWatch the presentation >
CVD and omega-3 fatty acids: Is arterial inflammation the key?
Professor Magnus BäckWatch the presentation >
What is your choice of therapeutic target for TG lowering? The cardiologist’s viewpoint
Professor David HareWatch the presentation >
What is your choice of therapeutic target for TG lowering? The endocrinologist’s viewpoint
Professor Klaus ParhoferWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
